Gyala Therapeutics
PrivateLast Round
Grant
Feb 11, 2026
Total Funding Raised
$9.64M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Gyala Therapeutics is a biotechnology company developing next-generation immunotherapies for hematological cancers with high unmet need.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2G
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gyala Therapeutics Comparables
Compare Gyala Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OneChain Immunotherapeutics | 86% | |
| iCell Gene Therapeutics | 76% | |
| AvenCell | 73% |
Gyala Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 11, 2026 | ||||
| Seed | Sep 15, 2025 | ||||
| VC Round | Oct 14, 2024 | ||||
| Seed | May 26, 2020 |
Gyala Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nara Capital | VC Round, Seed |
| Center for Technological Development and Innovation | VC Round, Seed |
| Invivo Partners | VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 15, 2025
First-in-class therapy targets CD84, showing preclinical efficacy in leukemias.
- Sep 15, 2025
$4M raised from Invivo Partners and Nara Capital.
Gyala Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Gyala Therapeutics's valuation, stock price, and market status.
Is Gyala Therapeutics a public or private company?
Gyala Therapeutics is a private company.
What is the current stock price of Gyala Therapeutics?
Gyala Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Gyala Therapeutics worth (valuation)?
Valuation information for Gyala Therapeutics is not publicly available.
Can I buy Gyala Therapeutics stock?
Gyala Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Gyala Therapeutics's last funding round?
Funding round information for Gyala Therapeutics is not publicly available.
Who are the main investors in Gyala Therapeutics?
Investor information for Gyala Therapeutics is not publicly disclosed.
Will Gyala Therapeutics IPO soon?
No public IPO plans have been announced for Gyala Therapeutics.
How can I track Gyala Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Gyala Therapeutics's secondary market activity and sign up for updates.